lymphedema edema
Conditions
Interventions
Among the lymphedema patients, those who receive lymphoscintigraphy for the diagnosis of lymphedema or those who receive lymphoscintigraphy for routine medical care for follow-up of lymphedema are the
Sponsors
YOSHIHIRO KIMATA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who had lymphscintigraph for diagnosis of lymphatic function or for follow-up to evaluate worsening lymphatic function 2. age over 20 3. patients with infrmed consent
Exclusion criteria
Exclusion criteria: 1. Patients with a body temperature of 38 degrees Celsius or higher (heated period) 2. Obese patients with lean body mass index (BMI value 18 or less) or BMI value 30 or more 3. Patients with pulmonary edema due to congestive heart failure 4. Patients with deep vein thrombosis, thrombophlebitis, pulmonary embolism or suspected of them 5. Patients with inflammation such as gangrene and wounds on the skin pressed by the sleeve 6. Patients with inflammation such as fractures, ablation, flesh, sprains, tendon sheath inflammation, and wounds in the musculoskeletal system compressed by the sleeve. 7. Patients with sensory impairment in the area compressed by the sleeve 8. Patients using implantable medical electrical equipment such as pacemakers that are susceptible to electromagnetic interference 9. Patients with a history of allergies to 99mTc 10. Pregnant patients 11. Patients who did not obtain document consent 12. Other patients who are judged to be inappropriate as subjects by the principal investigator and the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in tracer counts around inguinal and popliteal lymph nodes by lymphscintigraphy at rest and the medical device is used for 10 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Difference in the number of counts depending on mild (stage 0 to 2 early) and severe (stage 2 lat e to 3) in the ISL lymphedema classification 2. Adverse events and malfunctions 3. Change in the number of counters for each imaging range 4. Change in the number of counters at the tracer injection site (back of the foot) 5. Remaining site of anatomical lymphatic groups (popliteal and inguinal) in lymphatic scintigraphy a nd Maegawa classification(type1-5, unclassified) | — |
Contacts
Public ContactSHINAOKA AKIRA
Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences
Outcome results
None listed